Thomas A. Davis Net Worth & Insider Trades

Thomas A. Davis - Executive VP & CMO, Celldex Therapeutics, Inc

As of June 16, 2017

What is Thomas A. Davis's Net Worth?

The current estimated net worth of Celldex Therapeutics, Inc's Executive VP & CMO, Thomas A. Davis, is estimated to be about $255.45K . Thomas A. Davis owns about 1,011 units of Celldex Therapeutics, Inc common stock. In the last 8 years at Celldex Therapeutics, Inc, Thomas A. Davis has sold an estimated value of $0 worth.

What is Thomas A. Davis's Past Insider Trading?

Thomas A. Davis's largest purchase order was 2,500 units , worth over $9.44K on September 17, 2010. In total, Thomas A. Davis has made about 10 transactions over 8 years of their time at Celldex Therapeutics, Inc. Thomas A. Davis usually trades in June, with the busiest year in 2010.

Thomas A. Davis

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Thomas A. Davis's' Mailing Address?

  • Mailing address is 65 West Watkins Mill Road Gaithersburg MD 20878 MD

Celldex Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

What are Celldex Therapeutics, Inc's Past Insider Trades?

Celldex Therapeutics, Inc's most recent insider trade came on December 9, 2022 by Tibor Keler who sold 16,860 units worth $622.61K . In the last 14 years, insiders at Celldex Therapeutics, Inc have sold an estimated value of $32.29M and bought an estimated value of $5.89M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Gerald McMahon, Director,  Anthony S Marucci, PRESIDENT & CEO,  and Avery W Catlin, Sr. VP & CFO .

Celldex Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...